Medicine - Liver Diseases

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Liver 82%
3. Hepacivirus 78%
4. Liver Transplantation 76%
5. Fibrosis 70%
6. Hepatic Stellate Cells 53%
7. Hepatitis C 46%
8. Liver Diseases 39%
9. Liver Cirrhosis 33%
10. HIV 30%
11. Ribavirin 28%
12. Therapeutics 28%
13. Chronic Hepatitis C 27%
14. Neoplasms 26%
15. Liver Neoplasms 20%
16. Non-alcoholic Fatty Liver Disease 20%
17. Antiviral Agents 19%
18. Sorafenib 18%
19. Virus Diseases 18%
20. Interferons 18%
21. Fatty Liver 18%
22. Survival 16%
23. Transplant Recipients 16%
24. Wounds and Injuries 16%
25. Biliary Liver Cirrhosis 16%
26. Transplants 15%
27. Hepatitis B 15%
28. Hepatitis B virus 14%
29. Hepatocytes 14%
30. Genotype 14%
31. Hepatitis 13%
32. Autoimmune Hepatitis 13%
33. Genes 12%
34. Biopsy 12%
35. Biomarkers 12%
36. Transplantation 12%
37. Chronic Hepatitis B 12%
38. Sustained Virologic Response 11%
39. Allografts 11%
40. Sofosbuvir 11%
41. Chronic Disease 11%
42. Portal Hypertension 11%
43. Coinfection 11%
44. Tissue Donors 10%
45. Alcoholic Hepatitis 10%
46. Recurrence 10%
47. Infections 9%
48. Chemical and Drug Induced Liver Injury 9%
49. Mortality 9%
50. Placebos 9%
51. Safety 9%
52. RNA 9%
53. Collagen 9%
54. Kruppel-Like Factor 6 8%
55. Mutation 8%
56. peginterferon alfa-2a 8%
57. Alcohols 8%
58. Acute Liver Failure 8%
59. Transforming Growth Factors 8%
60. Clinical Trials 7%
61. Living Donors 7%
62. Inflammation 7%
63. Pharmaceutical Preparations 7%
64. Cholangiocarcinoma 7%
65. Extracellular Matrix 7%
66. Proteins 7%
67. ramucirumab 7%
68. Serum 7%
69. Apoptosis 7%
70. Sclerosing Cholangitis 7%
71. End Stage Liver Disease 6%
72. Population 6%
73. telaprevir 6%
74. Gene Expression 6%
75. sofosbuvir drug combination ledipasvir 6%
76. Incidence 6%
77. HIV Infections 6%
78. Cell Line 6%
79. Autophagy 6%
80. Coronavirus 6%
81. Ascites 5%
82. Myofibroblasts 5%
83. Graft Survival 5%
84. alpha-Fetoproteins 5%
85. Confidence Intervals 5%
86. Gastroenterology 5%
87. Epigenomics 5%
88. Discoidin Domain Receptor 2 5%
89. Transcriptional Activation 5%
90. Transcriptome 5%
91. Tenofovir 5%
92. Messenger RNA 5%